Using both miRTarBase and DIANA-TarBase, we predicted the miRNAs which might bind PRAS40 3'UTR and then focused on those that are downregulated in the plasma of patients with TSC but are reversed by everolimus treatment [24]. The gene discussed is AKT1S1; the disease is tuberous sclerosis.